PharmaCyte Biotech, Inc. (Nasdaq:PMCB)
N/A • N/A
CIK 1157075
Company
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.
Address
N/A
N/A
Employees
None
None
Stock Info
Key Executives
Board Of Directors
SEC filings
Date | Form | Event |
---|---|---|
13 Dec, 2024 | 10-Q | |
4 Dec, 2024 | S-8 | |
13 Nov, 2024 | SC 13G/A | |
17 Sep, 2024 | NT 10-Q | |
17 Sep, 2024 | 10-Q | |
13 Aug, 2024 | 10-K | |
29 Jul, 2024 | NT 10-K | |
17 Jul, 2024 | 4 | |
17 Jul, 2024 | 4 | |
17 Jul, 2024 | 4 | |
17 Jul, 2024 | 4 | |
30 May, 2024 | SC 13D | |
30 May, 2024 | 3 | |
23 May, 2024 | 8-K | |
1 May, 2024 | 8-K | |
27 Mar, 2024 | ARS | |
27 Mar, 2024 | DEF 14A | |
18 Mar, 2024 | 10-Q | |
14 Feb, 2024 | SC 13G | |
6 Feb, 2024 | SC 13G/A | |
15 Dec, 2023 | 10-Q | |
28 Nov, 2023 | 3 | |
24 Nov, 2023 | 8-K | |
22 Nov, 2023 | 4 | |
22 Nov, 2023 | SC 13D | |
22 Nov, 2023 | 4 | |
22 Nov, 2023 | 4 | |
22 Nov, 2023 | 4 | |
22 Nov, 2023 | 4 | |
22 Nov, 2023 | 4 | |
16 Nov, 2023 | 8-K | |
9 Nov, 2023 | 8-K | |
29 Sep, 2023 | EFFECT | |
27 Sep, 2023 | CORRESP | |
21 Sep, 2023 | S-3/A | |
18 Sep, 2023 | 10-Q | |
15 Sep, 2023 | NT 10-Q | |
12 Sep, 2023 | S-3/A | |
7 Sep, 2023 | 8-K | |
4 Aug, 2023 | 8-K | |
4 Aug, 2023 | CORRESP | |
4 Aug, 2023 | S-3/A | |
31 Jul, 2023 | DEF 14A | |
31 Jul, 2023 | 10-K | |
19 Jul, 2023 | 8-K | |
19 Jul, 2023 | PRE 14A | |
26 Jun, 2023 | UPLOAD | |
16 Jun, 2023 | SC 13D/A | |
15 Jun, 2023 | SC TO-I/A | |
9 Jun, 2023 | S-3 | |
5 Jun, 2023 | CORRESP | |
5 Jun, 2023 | DEF 14A | |
30 May, 2023 | CORRESP | |
25 May, 2023 | PRE 14A | |
19 May, 2023 | UPLOAD | |
19 May, 2023 | SC 13G | |
12 May, 2023 | SC 13D/A | |
11 May, 2023 | SC TO-I | |
11 May, 2023 | 8-K | |
16 Mar, 2023 | 10-Q | |
14 Feb, 2023 | SC 13G/A | |
8 Feb, 2023 | SC 13G/A | |
2 Feb, 2023 | 8-K | |
10 Jan, 2023 | SC 13G/A | |
30 Dec, 2022 | 8-K | |
30 Dec, 2022 | 4 | |
30 Dec, 2022 | 4 | |
30 Dec, 2022 | 3 | |
14 Dec, 2022 | 10-Q | |
18 Nov, 2022 | 8-K | |
16 Nov, 2022 | 3 | |
15 Nov, 2022 | PRE 14A | |
7 Nov, 2022 | 8-K | |
20 Oct, 2022 | SC 13G | |
14 Oct, 2022 | 8-K | |
7 Oct, 2022 | 8-K | CEO Change |
14 Sep, 2022 | 10-Q | |
24 Aug, 2022 | 3 | |
23 Aug, 2022 | 3 | |
23 Aug, 2022 | 3 | |
23 Aug, 2022 | 3 | |
23 Aug, 2022 | 3 | |
16 Aug, 2022 | DEFA14A | |
16 Aug, 2022 | 8-K | |
15 Aug, 2022 | SC 13D/A | |
28 Jul, 2022 | 10-K | |
28 Jul, 2022 | 8-K | |
28 Jul, 2022 | DFAN14A | |
28 Jul, 2022 | DEFA14A | |
26 Jul, 2022 | PREC14A | |
21 Jul, 2022 | 8-K | |
21 Jul, 2022 | DEFA14A | |
19 Jul, 2022 | 8-K | |
19 Jul, 2022 | DEFA14A | |
11 Jul, 2022 | DEFA14A | |
11 Jul, 2022 | 8-K | |
11 Jul, 2022 | SC 13D/A | |
11 Jul, 2022 | DFAN14A | |
5 Jul, 2022 | DFAN14A | |
23 Jun, 2022 | SC 13D/A | |
23 Jun, 2022 | DFAN14A | |
15 Jun, 2022 | 8-K | |
15 Jun, 2022 | DEFA14A | |
7 Jun, 2022 | 8-K | |
13 Apr, 2022 | 8-K | |
11 Apr, 2022 | 3 | |
5 Apr, 2022 | 8-K | |
15 Mar, 2022 | 10-Q | |
9 Mar, 2022 | 8-K | |
1 Mar, 2022 | 8-K | |
17 Feb, 2022 | 8-K | |
11 Feb, 2022 | SC 13G/A | |
4 Jan, 2022 | SC 13G/A | |
14 Dec, 2021 | 10-Q | |
22 Nov, 2021 | 424B3 | |
17 Nov, 2021 | EFFECT | |
15 Nov, 2021 | UPLOAD | |
15 Nov, 2021 | CORRESP | |
8 Nov, 2021 | S-3 | |
4 Nov, 2021 | SC 13D | |
14 Sep, 2021 | 10-Q | |
10 Sep, 2021 | 8-K | |
3 Sep, 2021 | 3 | |
1 Sep, 2021 | D | |
31 Aug, 2021 | 3 | |
31 Aug, 2021 | 3 | |
31 Aug, 2021 | 3 | |
30 Aug, 2021 | SC 13G | |
30 Aug, 2021 | SC 13G | |
23 Aug, 2021 | 424B5 | |
23 Aug, 2021 | 8-K | |
20 Aug, 2021 | 3 | |
20 Aug, 2021 | 3 | |
20 Aug, 2021 | 3 | |
19 Aug, 2021 | S-3MEF | |
12 Aug, 2021 | 8-K | |
10 Aug, 2021 | CERT | |
10 Aug, 2021 | 424B5 | |
10 Aug, 2021 | 10-K | |
2 Aug, 2021 | 424B5 | |
2 Aug, 2021 | 8-K | |
2 Aug, 2021 | 8-A12B | |
29 Jul, 2021 | NT 10-K | |
13 Jul, 2021 | 8-K | |
6 Jul, 2021 | 8-K | |
22 Jun, 2021 | 8-K | |
15 Jun, 2021 | 8-K | |
4 Jun, 2021 | 8-K | |
6 May, 2021 | 8-K | |
14 Apr, 2021 | EFFECT | |
12 Apr, 2021 | CORRESP | |
9 Apr, 2021 | UPLOAD | |
5 Apr, 2021 | S-3 | |
12 Mar, 2021 | 10-Q |
Last update:2024-03-06 12:43:23.760298
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.